The new mice study builds on previous studies that found COVID-19 doubled patients' risk of dying from cancer.

A research team has developed a technology that distinguishes lung cancer gene mutations solely by measuring the "stiffness" ...

Cancer cells mount an instant, energy‑rich response to being physically squeezed, according to a study published in the ...

A professor at the Indiana Univesity Luddy School of Informatics, Computing and Engineering has co-authored a paper ...

The drug targets the overgrowth of synovial cells and inflammatory components that drive tumor development and joint ...

Vimseltinib is the first and only therapy with a positive CHMP opinion for the treatment of TGCT in the European Union Deciphera Pharmaceuticals, LLC, a biopharmaceutical company focused on discoverin ...

Deciphera Pharmaceuticals, LLC, a biopharmaceutical company focused on discovering, developing, and commercializing important ...

ASCO 2025 showcased breakthroughs in sarcoma treatment, emphasizing precision medicine, immunotherapy, and promising new ...

A new AI tool, AAnet, has discovered five distinct cell types within tumors, offering a deeper look into cancer's inner diversity. This insight could transform how we treat cancer, enabling ...

DARMSTADT, Germany-- (BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical ...

Giant cell tumor of bone (GCTB) is a locally aggressive tumor predominantly presenting in the bones around the knee joint of adults between the ages of 20 and 50 years. GCTB represents 20% of benign ...